Evidence map›Paper›PMID 39149484›Full record

ArticleResearch square2024

Apolipoprotein E is a novel marker for chondrocytes in the growth plate resting zone.

Satoru Otsuru, Joe Kodama, Takeshi Oichi, Kevin Wilkinson, Joshua Abzug, Takashi Kaito, Motomi Iwamoto-Enomoto, Masahiro Iwamoto

Abstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Satoru OtsuruUniversity of Maryland, Baltimore.ORCID 0000-0002-9233-6614
Joe KodamaUniversity of Maryland.ORCID 0000-0001-8331-7772
Takeshi OichiUniversity of Maryland, Baltimore.ORCID 0000-0002-8009-1648
Kevin WilkinsonUniversity of Maryland.
Joshua AbzugUniversity of Maryland.
Takashi KaitoOsaka University.
Motomi Iwamoto-EnomotoUniversity of Maryland, Baltimore.ORCID 0000-0002-9589-9607
Masahiro Iwamotounknown.

Funding

Mechanism of growth deficiency in dominant forms of osteogenesis imperfectaR01AR075733 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI OTSURU, SATORU · 2020 to 2024
$1.7M
Lipid metabolism in the growth plateR01AR083363 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI Satoru Otsuru · 2024 to 2026
$1.6M
Development of a novel therapy with Apolipoprotein E for osteogenesis imperfectaR21AR077654 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI OTSURU, SATORU · 2020 to 2021
$369k
Advanced components for an existing spinning disk confocal in an established core imaging facilityS10OD026698 · OD · UNIVERSITY OF MARYLAND BALTIMORE · PI BLANPIED, THOMAS A · 2019 to 2019
$274k
NIAMS NIH HHS R01 AR075733NIAMS NIH HHS R01 AR083363NIAMS NIH HHS R21 AR077654NIH HHS S10 OD026698
6 · The paper itself

Abstract

The resting zone (RZ) in mammalian growth plates is critical for maintaining and regulating chondrocyte turnover during longitudinal bone growth as a control tower and stem cell reservoir. Although recent lineage tracing studies have identified several markers for stem cells in the RZ, these markers only partially label chondrocytes in the RZ, suggesting that the resting chondrocytes (RCs) are a heterogeneous population with different types of stem cells. Since a comprehensive marker for RCs is still lacking, the RZ is generally determined based on ambiguous histological criteria, such as small and round chondrocytes without columnar formation, which may lead to inconsistencies among researchers. Therefore, in this study, we used single-cell RNA sequencing (scRNAseq) of growth plate chondrocytes followed by validation by fluorescence in situ hybridization (FISH) to precisely annotate cell clusters in scRNAseq and search for a marker of RCs. The scRNAseq analysis revealed that apolipoprotein E (

Identifiers

PMID39149484
PMCPMC11326366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.